There was also Levodopa-induced dyskinesia in one patient who carries both the LRRK2 p.G2019S and parkin exon 5 duplication: this was marked peak-dose dyskinesia of choreic type involving extremities (with gait being almost impossible) and accompanied by dystonic anterocollis[10]. This evidence concerns the gene PRKN and drug-induced dyskinesia.